Literature DB >> 8431135

Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort.

D W Desmond1, T K Tatemichi, M Paik, Y Stern.   

Abstract

We investigated the relationship between risk factors for cerebrovascular disease and cognitive function in 249 stroke-free community volunteers (age, 70.8 +/- 6.7 years; education, 12.3 +/- 4.6 years) who were given tests of memory, language, visuospatial, abstract reasoning, and attentional skills. Using logistic regression analyses, we examined hypertension, diabetes mellitus, myocardial infarction, angina, hypercholesterolemia, and cigarette smoking as potential correlates of performance within these cognitive domains. Controlling for demographic factors within the logistic models, diabetes mellitus was a significant independent correlate of abstract reasoning deficits (odds ratio, 10.9; 95% confidence interval, 2.2 to 54.9) and visuospatial dysfunction (odds ratio, 3.5; confidence interval, 1.2 to 10.7), while hypercholesterolemia was a significant independent correlate of memory dysfunction (odds ratio, 3.0; confidence interval, 1.4 to 6.6). Prolonged exposure to vascular risk factors such as diabetes mellitus and hypercholesterolemia may lead to atherosclerotic disease, possibly resulting in "silent" infarctions or impaired cerebral blood flow and a decline in cognitive functioning.

Entities:  

Mesh:

Year:  1993        PMID: 8431135     DOI: 10.1001/archneur.1993.00540020040015

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  42 in total

Review 1.  Prevention of Alzheimer's disease: where we stand.

Authors:  Mary Sano
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

2.  Effect of cognitive status on exercise performance and quality of life in patients with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Shari R Waldstein; Polly S Montgomery; Yan D Zhao
Journal:  J Vasc Surg       Date:  2015-10-23       Impact factor: 4.268

3.  Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factors.

Authors:  Jesse Mez; Stephanie Cosentino; Adam M Brickman; Edward D Huey; Jennifer J Manly; Richard Mayeux
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jul-Sep       Impact factor: 2.703

4.  Neurovascular changes measured by time-of-flight MR angiography in cholesterol-fed rabbits with cortical amyloid beta-peptide accumulation.

Authors:  Susan K Lemieux; Carrie A Smith-Bell; Jered R Wells; Nnadozie M Ezerioha; Jeffrey S Carpenter; D Larry Sparks; Bernard G Schreurs
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

Review 5.  LXR agonists: new potential therapeutic drug for neurodegenerative diseases.

Authors:  Pei Xu; Dabing Li; Xiaotong Tang; Xiaohang Bao; Jing Huang; Yongping Tang; Yang Yang; Haiwei Xu; Xiaotang Fan
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

6.  Neuroepidemiology of vascular and Alzheimer's dementia among African-American women.

Authors:  Y Harris; P B Gorelick; S Freels; M Billingsley; N Brown; D Robinson
Journal:  J Natl Med Assoc       Date:  1995-10       Impact factor: 1.798

7.  Chronic kidney disease, creatinine and cognitive functioning.

Authors:  Merrill F Elias; Penelope K Elias; Stephen L Seliger; Sriram S Narsipur; Gregrory A Dore; Michael A Robbins
Journal:  Nephrol Dial Transplant       Date:  2009-03-18       Impact factor: 5.992

8.  The impact of vascular comorbidities on qualitative error analysis of executive impairment in Alzheimer's disease.

Authors:  Melissa Lamar; David J Libon; Angela V Ashley; James J Lah; Allan I Levey; Felicia C Goldstein
Journal:  J Int Neuropsychol Soc       Date:  2009-10-19       Impact factor: 2.892

9.  On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks.

Authors:  Marwan N Sabbagh; Kabir Thind; David Larry Sparks
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Oct-Dec       Impact factor: 2.703

Review 10.  Vascular dementia: prevention and treatment.

Authors:  Catherine McVeigh; Peter Passmore
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.